An MM - Search Results

1

Fcr1p inhibits development of fluconazole resistance in Candida albicans by abolishing CDR1 induction.

Shen H, An MM, Wang de J, Xu Z, Zhang JD, Gao PH, Cao YY, Cao YB, Jiang YY. Shen H, et al. Among authors: an mm. Biol Pharm Bull. 2007 Jan;30(1):68-73. doi: 10.1248/bpb.30.68. Biol Pharm Bull. 2007. PMID: 17202662 Free article.

2

Lymphtoxin beta receptor-Ig ameliorates TNBS-induced colitis via blocking LIGHT/HVEM signaling.

An MM, Fan KX, Zhang JD, Li HJ, Song SC, Liu BG, Gao PH, Zhou Q, Jiang YY. An MM, et al. Pharmacol Res. 2005 Sep;52(3):234-44. doi: 10.1016/j.phrs.2005.03.009. Pharmacol Res. 2005. PMID: 15925518

3

Antifungal activities and action mechanisms of compounds from Tribulus terrestris L.

Zhang JD, Xu Z, Cao YB, Chen HS, Yan L, An MM, Gao PH, Wang Y, Jia XM, Jiang YY. Zhang JD, et al. Among authors: an mm. J Ethnopharmacol. 2006 Jan 3;103(1):76-84. doi: 10.1016/j.jep.2005.07.006. Epub 2005 Oct 5. J Ethnopharmacol. 2006. PMID: 16169173

4

In vitro and in vivo antifungal activities of the eight steroid saponins from Tribulus terrestris L. with potent activity against fluconazole-resistant fungal pathogens.

Zhang JD, Cao YB, Xu Z, Sun HH, An MM, Yan L, Chen HS, Gao PH, Wang Y, Jia XM, Jiang YY. Zhang JD, et al. Among authors: an mm. Biol Pharm Bull. 2005 Dec;28(12):2211-5. doi: 10.1248/bpb.28.2211. Biol Pharm Bull. 2005. PMID: 16327151 Free article.

5

Lymphtoxin beta receptor-Ig protects from T-cell-mediated liver injury in mice through blocking LIGHT/HVEM signaling.

An MM, Fan KX, Cao YB, Shen H, Zhang JD, Lu L, Gao PH, Jiang YY. An MM, et al. Biol Pharm Bull. 2006 Oct;29(10):2025-30. doi: 10.1248/bpb.29.2025. Biol Pharm Bull. 2006. PMID: 17015945 Free article.

6

Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans.

An M, Shen H, Cao Y, Zhang J, Cai Y, Wang R, Jiang Y. An M, et al. Int J Antimicrob Agents. 2009 Mar;33(3):258-63. doi: 10.1016/j.ijantimicag.2008.09.014. Epub 2008 Dec 17. Int J Antimicrob Agents. 2009. PMID: 19095412

7

The addition of tocilizumab to DMARD therapy for rheumatoid arthritis: a meta-analysis of randomized controlled trials.

An MM, Zou Z, Shen H, Zhang JD, Cao YB, Jiang YY. An MM, et al. Eur J Clin Pharmacol. 2010 Jan;66(1):49-59. doi: 10.1007/s00228-009-0754-0. Epub 2009 Nov 21. Eur J Clin Pharmacol. 2010. PMID: 19936725

8

Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials.

An MM, Zou Z, Shen H, Zhang JD, Chen ML, Liu P, Wang R, Jiang YY. An MM, et al. BMC Infect Dis. 2009 Dec 2;9:193. doi: 10.1186/1471-2334-9-193. BMC Infect Dis. 2009. PMID: 19951447 Free PMC article.

9

Moxifloxacin monotherapy versus beta-lactam-based standard therapy for community-acquired pneumonia: a meta-analysis of randomised controlled trials.

An MM, Zou Z, Shen H, Gao PH, Cao YB, Jiang YY. An MM, et al. Int J Antimicrob Agents. 2010 Jul;36(1):58-65. doi: 10.1016/j.ijantimicag.2010.03.010. Epub 2010 Apr 18. Int J Antimicrob Agents. 2010. PMID: 20400271 Clinical Trial.

10

Incidence and risk of significantly raised blood pressure in cancer patients treated with bevacizumab: an updated meta-analysis.

An MM, Zou Z, Shen H, Liu P, Chen ML, Cao YB, Jiang YY. An MM, et al. Eur J Clin Pharmacol. 2010 Aug;66(8):813-21. doi: 10.1007/s00228-010-0815-4. Epub 2010 Apr 17. Eur J Clin Pharmacol. 2010. PMID: 20401474

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters